CEO & Co-Founder, Neuroendocrine Cancer UK For over twenty-five years, I have dedicated my career to transforming the care and outcomes for individuals affected by neuroendocrine cancer. At Neuroendocrine Cancer UK, our mission is clear: to stand beside every person facing a diagnosis of neuroendocrine cancer. Despite being the tenth most prevalent cancer in the UK, it remains widely misunderstood, frequently misdiagnosed, and critically under-recognised. It is, in many ways, a blind spot in cancer care—and that must change. Together with my team, I am committed to driving awareness, improving early diagnosis, and ensuring that every patient receives the support and care they deserve. The journey has brought its share of challenges, but also a profound sense of purpose and achievement.